Previously we have identified that the epidermis in SSc skin lesions is highly activated, and capable of stimulating local fibroblasts as well as releasing pro-inflammatory such as S100A9 as well as pro-fibrotic CTGF [4]. This evidence concerns the gene S100A9 and systemic sclerosis.